D. Mari

745 total citations
14 papers, 401 citations indexed

About

D. Mari is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, D. Mari has authored 14 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in D. Mari's work include Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (5 papers) and Lung Cancer Research Studies (4 papers). D. Mari is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (5 papers) and Lung Cancer Research Studies (4 papers). D. Mari collaborates with scholars based in Italy, United States and Brazil. D. Mari's co-authors include Francesco Graziano, Vincenzo Catalano, Paolo Giordani, D Rossi, Anna Maria Baldelli, Alfredo Falcone, Fotios Loupakis, U. Torresi, Lucio Giustini and Renato Bisonni and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

D. Mari

14 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Mari Italy	9	256	193	146	105	68	14	401
Hirotoshi Kobayashi Japan	12	412 1.6×	187 1.0×	225 1.5×	182 1.7×	48 0.7×	22	555
Maria Antista Italy	10	205 0.8×	69 0.4×	94 0.6×	57 0.5×	61 0.9×	26	300
Mitsuru Yokota Japan	11	206 0.8×	164 0.8×	105 0.7×	52 0.5×	35 0.5×	41	322
Hae‐Ran Yun South Korea	11	427 1.7×	250 1.3×	155 1.1×	119 1.1×	31 0.5×	17	524
Ken Kato Japan	12	187 0.7×	133 0.7×	160 1.1×	30 0.3×	52 0.8×	42	341
E. Leo Italy	7	169 0.7×	153 0.8×	68 0.5×	63 0.6×	146 2.1×	15	425
R. Doerr United States	9	120 0.5×	107 0.6×	95 0.7×	39 0.4×	46 0.7×	15	317
Victor Hugo Fonseca de Jesus Brazil	12	247 1.0×	134 0.7×	173 1.2×	20 0.2×	70 1.0×	57	410
Henry Walch United States	9	155 0.6×	73 0.4×	85 0.6×	65 0.6×	79 1.2×	44	280
Julien Volet France	10	262 1.0×	109 0.6×	119 0.8×	14 0.1×	51 0.8×	23	361

Countries citing papers authored by D. Mari

Since Specialization

Citations

This map shows the geographic impact of D. Mari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Mari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Mari more than expected).

Fields of papers citing papers by D. Mari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Mari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Mari. The network helps show where D. Mari may publish in the future.

Co-authorship network of co-authors of D. Mari

This figure shows the co-authorship network connecting the top 25 collaborators of D. Mari. A scholar is included among the top collaborators of D. Mari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Mari. D. Mari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Oliveira, Vani Xavier, et al.. (2023). Synergistic Effect of the Association of BR2 Peptide with 2-Aminoethyl Dihydrogen Phosphate in Triple-Negative Breast Cancer Cells. Archives of Breast Cancer. 148–158. 1 indexed citations

Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2011). Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Annals of Oncology. 23(1). 135–141. 88 indexed citations

Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2009). Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. British Journal of Cancer. 100(6). 881–887. 158 indexed citations

Catalano, Vincenzo, Fotios Loupakis, Francesco Graziano, et al.. (2008). Mucinous histology in advanced colorectal cancer patients treated with first-line irinotecan- and/or oxaliplatin-based chemotherapy. Journal of Clinical Oncology. 26(15_suppl). 4120–4120. 2 indexed citations

Graziano, Francesco, Annamaria Ruzzo, Fotios Loupakis, et al.. (2007). Pharmacogenetic profiling for anti-epidermal growth factor receptor (EGFR) therapy in (pts) with refractory advanced colorectal cancer (ACRC). CINECA IRIS Institutial research information system (University of Pisa). 1 indexed citations

Scartozzi, Mario, Gennaro Galizia, Rossana Berardi, et al.. (2006). Lymphatic, blood vessel and perineural invasion identifies early-stage high-risk radically resected gastric cancer patients. British Journal of Cancer. 95(4). 445–449. 37 indexed citations

Scartozzi, Mario, Gennaro Galizia, Francesco Graziano, et al.. (2005). Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients. British Journal of Cancer. 92(6). 1051–1054. 14 indexed citations

Graziano, Francesco, Annamaria Ruzzo, Alessandra Mandolesi, et al.. (2004). Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Annals of Oncology. 15(3). 489–492. 43 indexed citations

Cascinu, Stefano, Anna Maria Baldelli, Vincenzo Catalano, et al.. (2002). Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: A low cost effective regimen. British Journal of Cancer. 86(2). 213–217. 12 indexed citations

10.

Pivot, Xavier, Emmanuel Chamorey, Emmanuel Guardiola, et al.. (2001). Phase I and pharmacokinetic study of capecitabine and cisplatin in head and neck cancer patients. European Journal of Cancer. 37. S73–S74. 3 indexed citations

11.

Lippe, P., Diego Tummarello, D. Mari, et al.. (1999). Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study. Annals of Oncology. 10(2). 217–222. 25 indexed citations

12.

Tummarello, Diego, et al.. (1998). First line chemotherapy in patients with brain metastases from non-small and small cell lung cancer.. Oncology Reports. 5(4). 897–900. 8 indexed citations

13.

Tummarello, Diego, Francesco Graziano, D. Mari, et al.. (1995). Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.. PubMed. 14(5B). 2221–7. 8 indexed citations

14.

Tummarello, Diego, et al.. (1994). CHEMOTHERAPEUTIC TREATMENT IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - A FURTHER ATTEMPT TO MODULATE CISPLATIN, VINBLASTINE AND MITOMYCIN-C (PVM) SCHEDULE. Oncology Reports. 1(2). 415–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact